Form 4: Xeris Biopharma Holdings Director Sherman Acquires Shares Following Milestone Achievement
SEC Form 4
Director Jeffrey W. Sherman acquired 6,502 shares of Xeris Biopharma Holdings, Inc. common stock due to the achievement of a Keveyis sales milestone.
Summary
- On March 15, 2024, Jeffrey W. Sherman, a director of Xeris Biopharma Holdings, Inc., acquired 6,502 shares of common stock.
- This acquisition was a result of achieving the Keveyis sales milestone, which triggered the settlement of a Contingent Value Right (CVR).
- The reporting person's right to receive additional shares pursuant to this earn-out right became fixed and irrevocable on October 5, 2021, the effective time of the Merger.
- Following the transaction, Sherman directly owns 114,380 shares and indirectly owns 5,400 shares through the JEFFREY W SHERMAN LIVING TRUST U/A DTD 03/21/2001.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The director's acquisition of shares following a milestone achievement is generally a good sign, suggesting confidence in the company's performance. However, it's a routine transaction related to previously agreed terms.
Positives
- The achievement of the Keveyis sales milestone is a positive indicator for Xeris Biopharma Holdings, Inc.
- Director Sherman's acquisition of shares could be interpreted as a sign of confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of regulatory compliance for company insiders and provide transparency into their transactions in the company's stock.
Stakeholder Impact
- The acquisition of shares by a director could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/21/2001 | Date of the JEFFREY W SHERMAN LIVING TRUST U/A |
| 05/24/2021 | Date of the transaction agreement by and among Xeris Pharmaceuticals, Inc. ('Xeris'), Strongbridge Biopharma plc ('Strongbridge'), the Issuer ('HoldCo') and Wells MergerSub, Inc. |
| 10/05/2021 | Effective time of the Merger where HoldCo acquired the entire issued and to be issued ordinary share capital of Strongbridge, and MergerSub merged with and into Xeris |
| 03/15/2024 | Date of the transaction where Jeffrey W. Sherman acquired shares. |
| 04/11/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.